Skip to main content
Royal Society of Chemistry logoLink to Royal Society of Chemistry
. 2025 Jun 9;61(57):10606–10609. doi: 10.1039/d5cc02129d

Encasing the paramagnetic copper(ii)-ion by the ring-contracted corrin ligand of vitamin B12,

Christoph Kieninger a,b, Klaus Wurst c, Daniel Leitner c, Luis P Peters b,c, Dennis F Dinu b,c, Markus Wiedemair a,b, Marc-Kevin Zaretzke d, Martin Bröring d, Stephan Hohloch c, Klaus R Liedl b,c, Bernhard Kräutler a,b,
PMCID: PMC12174906  PMID: 40528401

Abstract

The d9-Cu(ii)-corrin cupribyrate (Cuby) was synthesized in 93% crystalline yield by rapid chelation of Cu2+-ions by the metal-free corrin-ligand of vitamin B12. Single crystals of the EPR-active Cuby allowed for the first X-ray structure determination of a Cu-corrin. SCF-calculations provided insights complementary to the experimental data of Cuby and indicated an out-of-plane displacement of the reduced d10-Cu(i)-ion, consistent with the observed reductive activation of Cuby towards loss of its Cu-center.


The encasement of a Cu(ii)-ion by the ring-contracted corrin-ligand of vitamin B12 leads to a tightly bound and nearly planar, 4-coordinate d9-Cu(ii)-centre, whose unpaired electron occupies a largely metal-located, antibonding dx2y2 orbital.graphic file with name d5cc02129d-ga.jpg


The ring-contracted natural corrin ligand of the B12-derivatives is a uniquely skewed, helical environment1,2 that binds cobalt-ions very tightly.3,4 This biosynthetically costly ligand for cobalt5,6 represents a precisely evolved entatic state module,2 giving B12-cofactors the unique capacity for their exceptional bio-organometallic catalysis.7–9 The complementary fundamental question, why cobalt? in B12-cofactors,1,3,9,10 has generated the long-standing experimental quest for non-cobalt analogues of the B12-derivatives,11,12 a challenge met by newly developed synthetic approaches.2,13 We have, thus, prepared Rh(iii)-,13–17 Ni(ii)-18 and Zn(ii)-complexes19 of natural corrin ligands for studies of their structures and reactivity. Here, we report on cupribyrate (Cuby) (Scheme 1), the Cu(ii)-complex of hydrogenobyric acid (Hby),2 including the first Cu-corrin X-ray crystal structure.

Scheme 1. Structure-based outline of the synthesis of cupribyrate (Cuby) from hydrogenobyric acid (Hby) (see the ESI) and the structural formula of Coαcyano, Coβaquo-cobyric acid (Coby).

Scheme 1

The complexation of metal-free Hby with Cu(ii)-ions occurred readily at room temperature (RT) in a 0.25 M aqueous solution of Cu(ii)-acetate at pH 6 and was practically quantitative within 90 min (see the ESI). It did not require the reported strong heating (‘brief boiling’).11,20 Crystallization of the raw Cuby-isolate from water/acetonitrile mixtures furnished Cuby in >93% yield.

The UV/Vis-spectrum (Fig. 1) of an aqueous solution of Cuby exhibits a corrin-type and is comparable to the earlier reported spectra of partially characterized Cu(ii)-corrins.20,21 UV/Vis- and CD-spectra of Cuby show remarkably similar features to the corresponding spectra of the Zn(ii)-complex19 of Hby, consistent with the dominating role of the corrin chromophore for the spectral signature in the UV- and Vis-range. A HR-ESI mass spectrum of Cuby confirmed the calculated molecular formula of C45H64CuN10O8 (see the ESI, Fig. S1).

Fig. 1. UV/Vis- and CD-spectra of Cuby (19 μM in 10 mM aqueous phosphate pH 7).

Fig. 1

Glassy frozen solutions of the paramagnetic Cu(ii)-corrin Cuby in 20% glycerol in H2O showed the typical EPR-signature (see Fig. 2, for a spectrum at T = 148 K) of a roughly square-planar 4-coordinate Cu(ii)-N4-complex with an index22,23 gII/AII = 98.2 cm, assigning an exceptionally low value to the encasement of the Cu(ii)-ion by the corrin ligand (see the ESI for further details).

Fig. 2. EPR-spectrum of a 1.34 mM frozen solution (at T = 148 K) of Cuby in H2O:glycerol (4 : 1) and its simulation with key parameters obtained by least square fitting (for details see the ESI, Table S1). The spectra exhibited a significant T-dependence, with a maximum signal intensity of around 200 K and continuous decrease at lower temperatures (see the ESI, Fig. S4).

Fig. 2

The neutral cupribyrate Cuby crystallized from an aqueous solution upon addition of acetonitrile. The monoclinic crystals (space group P21) contain two Cuby molecules per unit cell, as well as molecules of water and acetonitrile (ordered near the Cuby-carboxylate). The Cu(ii)-center of the Cuby molecule sits only +0.033 Å above the mean plane of the four ‘inner’ corrin N-atoms, which span an unsymmetrical and nearly planar coordination pattern (see Fig. 3), as reflected by the value of the geometry index τ4 = 0.17.24 However, Cuby exhibits a less planar arrangement around its 4-coordinate d9 Cu(ii)-center, than in the Ni(ii)-corrin nibyrate (Niby),18 which experiences a better fit of its 4-coordinate low-spin d8 Ni(ii)-ion (see the ESI, Table S3). The average Cu–N distance in Cuby amounts to 1.91 Å, merely 0.05 Å longer than in Niby, in which the 0.08 Å smaller low spin d8-ion Ni(ii)25 induced a slight contraction.18 In fact, binding of the d9 Cu(ii)-ion largely retains the architecture of the coordination hole of the metal-free corrin ligand Hby, expanded by two ‘inner’ protons.2 In Cuby, the critical angle parameters corrin-fold26 (10.0°) and corrin helicity2 (12.4°) are also similar to those of the ligand Hby,2 but remarkably larger than in Niby. Likewise, the angle between the planes N1–Cu–N2 and N3–Cu–N4 (roughly 13.6°) relating to the inner coordination-sphere around the Cu(ii)-center (see the ESI, Table S3) is close to the value derived for Hby.2 Interestingly, the N1–M–N3 pseudo-diagonal in Cuby was roughly 0.07 Å shorter than the N2–M–N4 counterpart, thus displaying a larger difference of the distances across these pseudo-diagonals than in Niby. This desymmetrization of the corrin core in Cuby also goes along the one observed in Hby and its Zn(ii)-complex,19 but is insignificant in the Co(ii)-corrins Co(ii)-cobalamin (CblII)27 and cob(ii)ester28 and in typical Co(iii)-corrins, such as coenzyme B12 (AdoCbl)29 and vitamin B12.30,31

Fig. 3. X-ray crystal structure of Cuby in ORTEP-representations. Top: axial view from above (β-side); bottom: approximate in-plane view, revealing the slightly nonplanar 4-fold coordination of the encased Cu(ii)-ion.

Fig. 3

Our self-consistent field (SCF) in the gas-phase calculation of cupribyric acid (HCuby+), the cationic carboxylate-protonated form of Cuby, used the atomic coordinates of the Cuby crystal structure. In this model, large artefactual electron density contributions of the carboxylate function of Cuby to occupied MOs were lacking, consistent with the experimental absence of such interactions. The so-derived computational insights into the bonding interactions of a d9-Cu(ii)-corrin were fully consistent with separately located calculated frontier molecular orbitals, either as π-type corrin ligand MOs or as the singly occupied dx2y2-type orbital on the Cu(ii)-center (see Fig. 4 and ESI Fig. S13). We also tested computed models of cuprobyric acid (Cu(i)by) to shed light on the difficult32 one-electron reduction to a d10-Cu(i)-corrin (for details, see the ESI, Fig. S14). The calculations suggest a large upper axial out of plane movement of the Cu(i)-ion, comparable to the position of the rather weakly bound Zn(ii)-center in zincobyric acid (Znby).19 Indeed, the iso-electronic nature of the closed shell d10-ions Cu(i) and Zn(ii) suggested the likelihood of the complete removal of a Cu(i)-ion from reduced Cuby in a weakly acidic aqueous medium. In an exploratory experiment, Cuby was treated with Zn-powder in an aqueous NH4Cl solution, leading to the effective replacement of the Cu-center of Cuby by Zn(ii), furnishing Znby,19 and its tentatively (by mass- and UV/Vis-spectroscopy) characterized dihydro-form H2-Znby, an unprecedented ring-reduced yellow corrinoid33,34 (see ESI, Scheme S1). We ascribe the observed formation of Znby from Cuby to a transient generation of an exchange-labile d10-Cu(i)-center by the Zn-reduction, thus strategically circumventing Eschenmoser's postulate that a B-type transition metal could not be removed without destruction of the corrin-ligand.35

Fig. 4. Frontier molecular orbitals (FMOs) of the cupribyric acid cation (HCuby+) from the self-consistent field in gas-phase calculations. From left to right: the highest occupied MO (HOMO), a corrin π-type orbital; the dx2y2-type Cu(ii)-located singly occupied MO (SOMO); and the lowest unoccupied MO (LUMO), a corrin π-type orbital. Orbitals are seen from the upper side.

Fig. 4

The replacement, by copper, of the biologically selected cobalt-center of a corrinoid B12-derivative1,36,37 erases its fundamental organometallic redox-reactivity.7 The single unpaired electron of the paramagnetic Cuby does not contribute any (cobalt-mimetic) radical reactivity, but is ‘buried’ in a dx2y2 orbital of its d9 Cu(ii)-center. Consistent with the EPR-spectral fingerprint of Cuby and its large 14N-hfcs with the four inner corrin N-atoms, in particular, the unpaired spin is located in a dx2y2 orbital of an effectively antibonding type with respect to the coordinating corrin N-atoms (Fig. 4). Compared to the d8 Ni(ii)-ion in Niby, the Cu(ii)–N bonds in Cuby are, indeed, longer. Copper complexes of the superficially similar corroles represent a remarkably more complex situation:38,39 there ‘non-innocence’ of the corrole ligand is caused by its extended π-system, assisting an intramolecular electron-shift and stabilizing the copper center in a higher oxidation state.40

The chelation of the fluorescent metal-free corrin Hby2,41 by Cu(ii)-ions in aqueous solution occurs cleanly at ambient temperature at pH 5. The Cu(ii)-ions chelate Hby with a rate kCu(II) = 0.54 ± 0.04 L mol−1 min−1, remarkably quicker by about 2 × 102 times than the binding of the biologically crucial Co(ii)-ions (kCo(II) of about 3 × 10−3 L mol−1 min−1), and five times faster than Zn(ii)-ions (kZn(II) = 0.111 ± 0.002 L mol−1 min−1, see the ESI). The chelation rates of these metal ions follow the trend established with Eschenmoser's model corrin35 and with a water-soluble tetra-mesopyridyl-porphyrin.42

Obviously, the biological roles of Co7,8,43 and Cu44–47 do not match. However, the 4-coordinate Cu(ii)-complexes of natural corrin ligands may serve as structural mimics of reduced B12-derivatives. In concert with the divergent reactivity profiles of copper- and cobalt-corrins, biologically interesting applications are likely. Cuby is structured similar to the corrin-core of enzyme-activated 4-coordinate Co(ii)-cobamides, first characterized in an ATP:Co(i)-corrinoid adenosyltransferase that generates AdoCbl from 4-coordinate Co(ii)-Cbl.48 With their largely inert 4-coordinate d9- and d8-metal-centers, respectively, Cu(ii)- and Ni(ii)-corrins18 may effectively mimic the structures of the highly activated 4-coordinate Co(ii)- and Co(i)-corrins. Indeed, nibalamin (Nibl), the diamagnetic Ni(ii)-analogue of ‘base-off’ Co(ii)-Cbl, was shown to be an effective inhibitor of the corrinoid adenosyltransferase BtuR from Brucella melitensis.18 The crystal structure of Cuby qualifies Cu(ii)-containing B12-derivatives, such as cupribalamin (Cubl), for similar inhibitory effects.

Transition metal analogues of vitamin B12 and other cobalamins (Cbls), also classified as metbalamins (Metbls),49,50 lack the precise cobalt-dependent reactivity of Cbls8,43 and, when mimicking Cbl-structures, may represent genuine antivitamins B12.50,51 This is the case for rhodibalamins (Rhbls), the Rh(iii)-homologues of Cbls. Surprisingly, their Rh(iii)-center has even been revealed to experience a slightly better fit to the corrin ligand than the naturally selected Co(iii)-ions.13–15 Whereas uptake and physiological activity of Metbls with stable 4-coordinate corrin-bound metal centers are still unknown in humans and animals, microorganisms are typically more structure-promiscuous for B12-import, satisfying their supply with cobamides by de novo biosynthesis5 or by partial assembly from salvaged natural corrinoids.52,53 As deduced for some Rhbls13,15 and for Nibl,18 transition metal-based structural mimics of B12-cofactors or of corrinoid B12-biosynthesis intermediates17 may selectively inhibit bacterial growth. As mimics of enzyme-bound Cbl-structures in B12-dependent enzymes at intermediate stages of catalysis, Metbls may specifically act as very effective enzyme inhibitors. The Cu(ii)-analogues of natural B12-derivatives are, hence, EPR-active candidates for their applications as B12-antimetabolites for B12-dependent microorganisms, an expansion of the toolbox of Cu-coordinating natural products47 as antimicrobial agents.

Synthetic, analytical and spectroscopic work: C. K. and M. W.; crystallography: C. K. and K. W.; theoretical and computational study: L. P. P., D. F. D., and K. R. L.; EPR-spectroscopy – data acquisition, supervision and data curation: D. L., M.-K. Z., M. B., and S. H.; and research conceptualization and conduction and original draft: B. K.; all authors have reviewed and contributed to the final draft.

We are particularly grateful to Evelyne Deery and Martin Warren for a generous supply of hydrogenobyric acid. This work was supported by the Austrian Science Fund (FWF projects P-28892 and P-33059 to BK and P-34626 to SH and DL).

Conflicts of interest

There are no conflicts to declare.

Supplementary Material

CC-061-D5CC02129D-s001
CC-061-D5CC02129D-s002

Dedicated to the memory of Albert Eschenmoser on the occasion of his 100th birthday.

Electronic supplementary information (ESI) available. CCDC 2402239. For ESI and crystallographic data in CIF or other electronic format see DOI: https://doi.org/10.1039/d5cc02129d

Data availability

See the ESI. Crystallographic data for cupribyrate (Cuby) have been deposited at the Cambridge Crystallographic Data Center (CCDC) and are available under accession number CCDC-2402239.

Notes and references

  1. Eschenmoser A. Angew. Chem., Int. Ed. Engl. 1988;27:5–39. doi: 10.1002/anie.198800051. [DOI] [Google Scholar]
  2. Kieninger C. Deery E. Lawrence A. D. Podewitz M. Wurst K. Nemoto-Smith E. Widner F. J. Baker J. A. Jockusch S. Kreutz C. R. Liedl K. R. Gruber K. Warren M. J. Kräutler B. Angew. Chem., Int. Ed. 2019;58:10756–10760. doi: 10.1002/anie.201904713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Pratt J. M., Inorganic Chemistry of Vitamin B12, Academic Press, New York, 1972 [Google Scholar]
  4. Lewis N. J. Nussberger R. Kräutler B. Eschenmoser A. Angew. Chem., Int. Ed. Engl. 1983;22:736–737. doi: 10.1002/anie.198307361. [DOI] [Google Scholar]
  5. Bryant D. A. Hunter C. N. Warren M. J. J. Biol. Chem. 2020;295:6888–6925. doi: 10.1074/jbc.REV120.006194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Raux E. Schubert H. L. Warren M. J. Cell. Mol. Life Sci. 2000;57:1880–1893. doi: 10.1007/PL00000670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kräutler B., in Adv. Bioorganomet. Chem., ed. T. Hirao and T. Moriuchi, Elsevier, Cambridge, USA, 2019, pp. 399–429 [Google Scholar]
  8. Brown K. L. Chem. Rev. 2005;105:2075–2149. doi: 10.1021/cr030720z. [DOI] [PubMed] [Google Scholar]
  9. Marques H. M. J. Coord. Chem. 2024;77:1161–1210. doi: 10.1080/00958972.2024.2343109. [DOI] [Google Scholar]
  10. Ochiai E.-I. J. Chem. Educ. 1978;55:631. doi: 10.1021/ed055p631. [DOI] [Google Scholar]
  11. V. B. Koppenhagen, in B12, ed. D. Dolphin, John Wiley & Sons, 1982, vol. 2, pp. 105–150 [Google Scholar]
  12. Holze G. Inhoffen H. H. Angew. Chem., Int. Ed. Engl. 1985;24:867–869. doi: 10.1002/anie.198508671. [DOI] [Google Scholar]
  13. Widner F. J. Lawrence A. D. Deery E. Heldt D. Frank S. Gruber K. Wurst K. Warren M. J. Kräutler B. Angew. Chem., Int. Ed. 2016;55:11281–11286. doi: 10.1002/anie.201603738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Widner F. J. Kieninger C. Wurst K. Deery E. Warren M. J. Kräutler B. Synthesis. 2021:332–337. [Google Scholar]
  15. Wiedemair M. Kieninger C. Wurst K. Podewitz M. Deery E. Paxhia M. D. Warren M. J. Kräutler B. Helv. Chim. Acta. 2023;106:e202200158. doi: 10.1002/hlca.202200158. [DOI] [Google Scholar]
  16. Ruetz M. Mascarenhas R. Widner F. Kieninger C. Koutmos M. Kräutler B. Banerjee R. Biochemistry. 2024;63:1955–1962. doi: 10.1021/acs.biochem.4c00216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Widner F. J. Kieninger C. Kraeutler B. J. Porph. Phthal. 2025;29:408–417. doi: 10.1142/S1088424625500348. [DOI] [Google Scholar]
  18. Kieninger C. Wurst K. Podewitz M. Stanley M. Deery E. Lawrence A. D. Liedl K. R. Warren M. J. Kräutler B. Angew. Chem., Int. Ed. 2020;59:20129–20136. doi: 10.1002/anie.202008407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kieninger C. Baker J. A. Podewitz M. Wurst K. Jockusch S. Lawrence A. D. Deery E. Gruber K. Liedl K. R. Warren M. J. Kräutler B. Angew. Chem., Int. Ed. 2019;58:14568–14572. doi: 10.1002/anie.201908428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Koppenhagen V. B. Pfiffner J. J. J. Biol. Chem. 1970;245:5865–5867. doi: 10.1016/S0021-9258(18)62733-4. [DOI] [PubMed] [Google Scholar]
  21. Koppenhagen V. B. Pfiffner J. J. J. Biol. Chem. 1971;246:3075–3077. doi: 10.1016/S0021-9258(18)62293-8. [DOI] [PubMed] [Google Scholar]
  22. Ray M. Mukherjee R. Richardson J. F. Mashuta M. S. Buchanan R. M. J. Chem. Soc., Dalton Trans. 1994:965–969. doi: 10.1039/DT9940000965. [DOI] [Google Scholar]
  23. Sakaguchi U. Addison A. W. J. Chem. Soc., Dalton Trans. 1979:600–608. doi: 10.1039/DT9790000600. [DOI] [Google Scholar]
  24. Yang L. Powell D. R. Houser R. P. Dalton Trans. 2007:955–964. doi: 10.1039/B617136B. [DOI] [PubMed] [Google Scholar]
  25. Cordero B. Gomez V. Platero-Prats A. E. Reves M. Echeverria J. Cremades E. Barragan F. Alvarez S. Dalton Trans. 2008:2832–2838. doi: 10.1039/B801115J. [DOI] [PubMed] [Google Scholar]
  26. Pett V. B. Liebman M. N. Murray-Rust P. Prasad K. Glusker J. P. J. Am. Chem. Soc. 1987;109:3207–3215. doi: 10.1021/ja00245a004. [DOI] [Google Scholar]
  27. Kräutler B. Keller W. Kratky C. J. Am. Chem. Soc. 1989;111:8936–8938. doi: 10.1021/ja00206a037. [DOI] [Google Scholar]
  28. Kräutler B. Keller W. Hughes M. Caderas C. Kratky C. J. Chem. Soc., Chem. Commun. 1987:1678–1680. doi: 10.1039/C39870001678. [DOI] [Google Scholar]
  29. Ouyang L. Rulis P. Ching W. Y. Nardin G. Randaccio L. Inorg. Chem. 2004;43:1235–1241. doi: 10.1021/ic0348446. [DOI] [PubMed] [Google Scholar]
  30. Kratky C. and Kräutler B., in Chemistry and Biochemistry of B12, ed. R. Banerjee, John Wiley & Sons, New York, Chichester, 1999, pp. 9–41 [Google Scholar]
  31. Kräutler B. Konrat R. Stupperich E. Färber G. Gruber K. Kratky C. Inorg. Chem. 1994;33:4128–4139. doi: 10.1021/ic00096a043. [DOI] [Google Scholar]
  32. Rubinson K. A. Caja J. Hurst R. W. Itabashi E. Kenyhercz T. M. Heineman W. R. Mark H. B. J. Chem. Soc., Chem. Commun. 1980:47–48. doi: 10.1039/C39800000047. [DOI] [Google Scholar]
  33. Schlingmann G. and Koppenhagen V. B., Zürich Switzerland, 1979
  34. Schlingmann G. Dresow B. Ernst L. Koppenhagen V. B. Liebigs Ann. Chem. 1981:2061–2066. doi: 10.1002/jlac.198119811114. [DOI] [Google Scholar]
  35. Blaser H. U. Winnacker E. L. Fischli A. Hardegger B. Bormann D. Hashimoto N. Schossig J. Keese R. Eschenmoser A. Helv. Chim. Acta. 2015;98:1845–1920. doi: 10.1002/hlca.201300064. [DOI] [Google Scholar]
  36. Holliday G. A. Thornton J. A. Marquet A. Smith A. G. Fabrice Rebeille F. Mendel R. Schubert H. L. Lawrence A. D. Warren M. J. Nat. Prod. Rep. 2007;24:972–1087. doi: 10.1039/B703107F. [DOI] [PubMed] [Google Scholar]
  37. Eschenmoser A. Angew. Chem., Int. Ed. 2011;50:12412–12472. doi: 10.1002/anie.201103672. [DOI] [PubMed] [Google Scholar]
  38. Ghosh A. Chem. Rev. 2017;117:3798–3881. doi: 10.1021/acs.chemrev.6b00590. [DOI] [PubMed] [Google Scholar]
  39. Bröring M. Brégier F. Tejero E. C. Hell C. Holthausen M. C. Angew. Chem., Int. Ed. 2007;46:445–448. doi: 10.1002/anie.200603676. [DOI] [PubMed] [Google Scholar]
  40. Lemon C. M. Huynh M. Maher A. G. Anderson B. L. Bloch E. D. Powers D. C. Nocera D. G. Angew. Chem., Int. Ed. 2016;55:2176–2180. doi: 10.1002/anie.201509099. [DOI] [PubMed] [Google Scholar]
  41. Jockusch S. Kräutler B. Chem. Commun. 2025;61:3904–3907. doi: 10.1039/D4CC06373B. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Hambright P., in The Porphyrin Handbook, Academic Press, 2000, vol. 3, pp. 129–210 [Google Scholar]
  43. Kräutler B., in Compreh. Organomet. Chem. IV, ed. G. Parkin, K. Meyer and D. O’Hare, Elsevier, Oxford, 2022, pp. 73–95 [Google Scholar]
  44. Solomon E. I. Szilagyi R. K. George S. D. Basumallick L. Chem. Rev. 2004;104:419–458. doi: 10.1021/cr0206317. [DOI] [PubMed] [Google Scholar]
  45. Kim E. Chufan E. E. Kamaraj K. Karlin K. D. Chem. Rev. 2004;104:1077–1133. doi: 10.1021/cr0206162. [DOI] [PubMed] [Google Scholar]
  46. Kenney G. E. Rosenzweig A. C. Ann. Rev. Biochem. 2018;87:645–676. doi: 10.1146/annurev-biochem-062917-012300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Manley O. M. Rosenzweig A. C. J. Biol. Inorg. Chem. 2025;30:111–124. doi: 10.1007/s00775-025-02099-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Maurice M. S. S. Mera P. Park K. Brunold T. C. Escalante-Semerena J. C. Rayment I. Biochemistry. 2008;47:5755–5766. doi: 10.1021/bi800132d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Zelder F. Sonnay M. Prieto L. ChemBioChem. 2015;16:1264–1278. doi: 10.1002/cbic.201500072. [DOI] [PubMed] [Google Scholar]
  50. Kräutler B. Chem. – Eur. J. 2020;26:15438–15445. doi: 10.1002/chem.202003788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Kräutler B. Chem. Eur. J. 2015;21:11280–11287. doi: 10.1002/chem.201502072. [DOI] [PubMed] [Google Scholar]
  52. Gude S. Pherribo G. J. Taga M. E. Msystems. 2022;7:00288. doi: 10.1128/msystems.00288-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Escalante-Semerena J. C. J. Bacteriol. 2007;189:4555–4560. doi: 10.1128/JB.00503-07. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

CC-061-D5CC02129D-s001
CC-061-D5CC02129D-s002

Data Availability Statement

See the ESI. Crystallographic data for cupribyrate (Cuby) have been deposited at the Cambridge Crystallographic Data Center (CCDC) and are available under accession number CCDC-2402239.


Articles from Chemical Communications (Cambridge, England) are provided here courtesy of Royal Society of Chemistry

RESOURCES